Dipeptidyl peptidase IV, which probably plays important roles in Alzheimer disease (AD) pathology, is upregulated in AD brain neurons and associates with amyloid plaques

被引：23
作者：
Bernstein, Hans-Gert [1 ]
Dobrowolny, Henrik [1 ]
Keilhoff, Gerburg [2 ]
Steiner, Johann [1 ]
机构：
[1] Otto v Guericke Univ Magdeburg, Dept Psychiat, Leipziger Str 44, D-39120 Magdeburg, Germany
[2] Otto v Guericke Univ Magdeburg, Inst Biochem & Cell Biol, Leipziger Str 44, D-39120 Magdeburg, Germany
来源：
NEUROCHEMISTRY INTERNATIONAL | 2018年 / 114卷
关键词：
DPP IV; Amyloid; Neurons; Immunohistochemistry; Alzheimer's disease; DPP-4; INHIBITOR; SITAGLIPTIN; DEMENTIA; INSULIN; BETA;
D O I：
10.1016/j.neuint.2018.01.005
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
There is evidence from in vitro experiments that dipeptidyl peptidase IV (DPP IV) might play role(s) in amyloid formation. However, nothing is known about the localization of the enzyme in brains of individuals with Alzheimer's disease. We herein show that in comparison to non-demented controls DPP IV is upregulated in AD brain neurons and occurs in multiple amyloid plaques. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码：55 / 57
页数：3
相关论文
共 20 条
  • [1] Antonyan A., NEUROCHEM INT, V113, P112
  • [2] AOYAGI T, 1993, J CLIN BIOCHEM NUTR, V14, P133
  • [3] Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
    Bassil, Fares
    Fernagut, Pierre-Olivier
    Bezard, Erwan
    Meissner, Wassilios G.
    [J]. PROGRESS IN NEUROBIOLOGY, 2014, 118 : 1 - 18
  • [4] Insulin-degrading enzyme in the Alzheimer's disease brain:: prominent localization in neurons and senile plaques
    Bernstein, HG
    Ansorge, S
    Riederer, P
    Reiser, M
    Frölich, L
    Bogerts, B
    [J]. NEUROSCIENCE LETTERS, 1999, 263 (2-3) : 161 - 164
  • [5] IMMUNOLOCALIZATION OF DIPEPTIDYL AMINOPEPTIDASE (DAP-IV) IN THE DEVELOPING HUMAN-BRAIN
    BERNSTEIN, HG
    SCHON, E
    ANSORGE, S
    ROSE, I
    DORN, A
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1987, 5 (03) : 237 - +
  • [6] Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice
    D'Amico, Michele
    Di Filippo, Clara
    Marfella, Raffaele
    Abbatecola, Angela Maria
    Ferraraccio, Franca
    Rossi, Francesco
    Paolisso, Giuseppe
    [J]. EXPERIMENTAL GERONTOLOGY, 2010, 45 (03) : 202 - 207
  • [7] Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-Aβ deposits in hippocampus via distinct cellular mechanisms
    Hartlage-Ruebsamen, Maike
    Morawski, Markus
    Waniek, Alexander
    Jaeger, Carsten
    Zeitschel, Ulrike
    Koch, Birgit
    Cynis, Holger
    Schilling, Stephan
    Schliebs, Reinhard
    Demuth, Hans-Ulrich
    Rossner, Steffen
    [J]. ACTA NEUROPATHOLOGICA, 2011, 121 (06) : 705 - 719
  • [8] Brain Pyroglutamate Amyloid-β is Produced by Cathepsin B and is Reduced by the Cysteine Protease Inhibitor E64d, Representing a Potential Alzheimer's Disease Therapeutic
    Hook, Gregory
    Yu, Jin
    Toneff, Thomas
    Kindy, Mark
    Hook, Vivian
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 41 (01) : 129 - 149
  • [9] The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease
    Isik, Ahmet Turan
    Soysal, Pinar
    Yay, Adnan
    Usarel, Cansu
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 123 : 192 - 198
  • [10] Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures
    Kim, Dong-Hou
    Huh, Jae-Wan
    Jang, Mi
    Suh, Jung-Hyun
    Kim, Tae-Wan
    Park, Jeong-Su
    Yoon, Seung-Yong
    [J]. NEUROBIOLOGY OF DISEASE, 2012, 46 (01) : 52 - 58
12